Literature DB >> 10689668

Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG.

A Lapolla1, D Fedele, M Garbeglio, L Martano, R Tonani, R Seraglia, D Favretto, M A Fedrigo, P Traldi.   

Abstract

The glycation-induced functional change of immunoglobulins is of particular interest. The glycation levels of IgG in 10 healthy subjects and 20 diabetic patients with different degrees of metabolic control were studied by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. It reveals the number of glucose molecules that have condensed on the protein, which range from 1 to 5 for healthy subjects, from 5 to 9 for well controlled diabetic patients, and from 10 to 25 for poorly controlled ones. The identification of the most favored glycation sites has been obtained by MALDI analysis of standard and in vitro glycated IgG and plasma protein fraction of a healthy subject after digestion with papain, releasing Fab and Fc fragments of the molecule. Both experiments, as well as molecular modeling of the whole protein, confirm that the most of glucose molecules have condensed on the Fab fragment of IgG, suggesting that the immune deficiency observed in diabetic patients may be explained at the molecular level by a more effective glycation of the Fab fragment, thus inhibiting the process of molecular recognition between antibody and antigen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689668     DOI: 10.1016/S1044-0305(99)00134-8

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.262


  25 in total

1.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

2.  Polyclonal immunoglobulin M: location of glycation sites.

Authors:  T Menini; A Gugliucci; A J Stahl
Journal:  Clin Chim Acta       Date:  1992-12-31       Impact factor: 3.786

Review 3.  Nonenzymatic glycosylation, the Maillard reaction and the aging process.

Authors:  V M Monnier
Journal:  J Gerontol       Date:  1990-07

4.  Impairment by glycation of immunoglobulin G Fc fragment function.

Authors:  R Dolhofer-Bliesener; K D Gerbitz
Journal:  Scand J Clin Lab Invest       Date:  1990-11       Impact factor: 1.713

Review 5.  Lilly Lecture 1993. Glycation and diabetic complications.

Authors:  M Brownlee
Journal:  Diabetes       Date:  1994-06       Impact factor: 9.461

6.  Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation.

Authors:  P J Hennessey; C T Black; R J Andrassy
Journal:  JPEN J Parenter Enteral Nutr       Date:  1991 Jan-Feb       Impact factor: 4.016

7.  Nonenzymic glycation of human immunoglobulins does not impair their immunoreactivity.

Authors:  L G Morin; G E Austin; G E Rodey; J E Johnson
Journal:  Clin Chem       Date:  1989-06       Impact factor: 8.327

8.  Evidence for an increased glycation of IgG in diabetic patients.

Authors:  P M Danze; A Tarjoman; J Rousseaux; P Fossati; M Dautrevaux
Journal:  Clin Chim Acta       Date:  1987-07-15       Impact factor: 3.786

9.  Impaired agglutination of IgM resulting from non-enzymatic glycation in diabetes mellitus.

Authors:  H P Hammes; V Kiefel; H Laube; K Federlin
Journal:  Diabetes Res Clin Pract       Date:  1990-04       Impact factor: 5.602

10.  Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation.

Authors:  R Dolhofer-Bliesener; B Lechner; K D Gerbitz
Journal:  Eur J Clin Chem Clin Biochem       Date:  1994-05
View more
  9 in total

1.  Correlation between molecular weight of plasma albumin determined with mass spectrometry and glycation indices in factory workers.

Authors:  Ichiro Nakamoto; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2004-03       Impact factor: 3.674

2.  Monitoring nonenzymatic glycation of human immunoglobulin G by methylglyoxal and glyoxal: A spectroscopic study.

Authors:  Praveen K Pampati; Sreekanth Suravajjala; Joel A Dain
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

3.  Impaired function of antibodies to pneumococcal surface protein A but not to capsular polysaccharide in Mexican American adults with type 2 diabetes mellitus.

Authors:  Christine E Mathews; Eric L Brown; Perla J Martinez; Upasana Bagaria; Moon H Nahm; Robert L Burton; Susan P Fisher-Hoch; Joseph B McCormick; Shaper Mirza
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

Review 4.  AGE/Non-AGE Glycation: An Important Event in Rheumatoid Arthritis Pathophysiology.

Authors:  Prachi Agnihotri; Sagarika Biswas
Journal:  Inflammation       Date:  2021-11-17       Impact factor: 4.092

Review 5.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Authors:  Qibin Zhang; Jennifer M Ames; Richard D Smith; John W Baynes; Thomas O Metz
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

6.  Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis.

Authors:  Marianna M Newkirk; Raphaela Goldbach-Mansky; Jennifer Lee; Joseph Hoxworth; Angie McCoy; Cheryl Yarboro; John Klippel; Hani S El-Gabalawy
Journal:  Arthritis Res Ther       Date:  2003-01-06       Impact factor: 5.156

Review 7.  Advanced glycation end products and diabetic complications.

Authors:  Varun Parkash Singh; Anjana Bali; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-02-13       Impact factor: 2.016

Review 8.  Maillard Proteomics: Opening New Pages.

Authors:  Alena Soboleva; Rico Schmidt; Maria Vikhnina; Tatiana Grishina; Andrej Frolov
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

9.  Exploiting the efficacy of Tyro3 and folate receptors to enhance the delivery of gold nanoparticles into colorectal cancer cells in vitro.

Authors:  Nakul Patel; Lucy Ghali; Ivan Roitt; Leonardo Puntoja Munoz; Richard Bayford
Journal:  Nanoscale Adv       Date:  2021-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.